Key result
ChAdOx1 nCoV-19 vaccination linked to acute polyserositis and impending cardiac tamponade in a 94-year-old man.
Why the study?
Although SARS-CoV-2 mRNA vaccines are known to be associated with pericarditis in young adults, data regarding other vaccine types are extremely limited.
Case Report (n=1)
No
This case highlights the potential for ChAdOx1 nCoV-19 vaccination to cause acute polyserositis presenting as cardiac tamponade and refractory pleural effusion.
Clinicians should consider post-vaccination polyserositis in acute presentations; single case leaves open causality and needs confirmation.
The association of SARS-CoV-2 messenger ribonucleic acid vaccines with pericarditis in young adults has been reported. However, data regarding other types of vaccines are extremely limited. We presented a 94-year-old man with rapidly progressive dyspnea and fatigue six days after his first ChAdOx1 nCoV-19 vaccination. Impending cardiac tamponade and bilateral pleural effusion were found. Hence, massive yellowish pericardial and pleural effusion were drained. However, the pleural effusion persisted and pigtail catheters were inserted bilaterally. After serial studies including surgical pleural biopsy, acute polyserositis (pericarditis and pleurisy) was diagnosed. Anti-inflammatory treatment with colchicine and prednisolone was administered. All effusions resolved accordingly. This rare case sheds light on the presentation of ChAdOx1 nCoV-19 vaccine-related acute polyserositis. In conclusion, awareness of this potential adverse event may facilitate the diagnosis for unexplained pericardial or pleural effusion after vaccination.
No takes yet. Share an insight, caveat, or question.
Li et al. (2022) conducted a case report in Acute polyserositis with cardiac tamponade and bilateral refractory pleural effusion (n=1). ChAdOx1 nCoV-19 vaccination was evaluated on Development of acute polyserositis. A 94-year-old man developed acute polyserositis with impending cardiac tamponade and bilateral refractory pleural effusion shortly after receiving his first ChAdOx1 nCoV-19 vaccination.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: